At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

JOB DESCRIPTION:

Johnson & Johnson Innovative Medicine is recruiting for an EMEA Integrated Brand Value Team Leader (IBVTL) – Nipocalimab.
The EMEA Integrated Brand Value Team Leader (IBVTL) – Nipocalimab (AutoAntibody & Maternal Fetal indications), reporting to the Regional Commercial Strategy Leader (RCSL) – Immunology, leads and executes the EMEA brand commercial strategy and tactics for key products and indications in the TAs, in alignment with global branding and positioning.
Working in global and regional cross-functional and highly matrixed teams, the IBVTL ensures that customer insights, environmental factors and unmet needs are reflected into Global plans and that EMEA launch readiness, product brand execution and resources are optimized.
The IBVTL is responsible for EMEA Brand budgets and monitors the performance, identifies critical opportunities and risks within the brand plan and evaluates investments for Regional Life Cycle opportunities.

QUALIFICATIONS

• The successful candidate has a background working in the healthcare sector, ideally including oncology. Ability and willingness to assimilate complex science and data quickly will be critical to understand a highly sophisticated and fast-moving market
• A proven track record of commercial leadership working within highly matrixed environments, including experience leading cross-functional teams and successful P&L management. Ideally including second line leadership and experience leading teams from multiple, diverse cultures or working in multiple geographies
• A minimum of a bachelor’s degree is required. An advanced degree in business or life sciences is preferred
• Demonstrated ability to build and work with HCP KOLs and external stakeholders is required
• Prior experience in working with external agencies and vendors is required
• In-line marketing experience across multiple brands including product launches is required.
• Experience in developing and implementing brand strategies for new products and/or significant success demonstrated in managing existing key brands is required
• An understanding of the drug development process is preferred
• This position requires up to 50% travel
  Location: The role will be based in your current country of residence as long as easy access to travel and local hosting is available at a JNJ IM EMEA office.
  Note for internals: Candidates should have the endorsement of their application from both their line manager and HR Director

• Continue to focus on the launch readiness of Nipocalimab in the first Neuroscience indication generalized Myasthenia Gravis (gMG) and establishes commercial strategies in full collaboration with key Global, Regional and Local stakeholders.
• Gathers and incorporates commercial insights from EMEA key stakeholders to inform Global Clinical Development Plans (CDPs) and Target Product Profiles (TPPs) for new indications in rare diseases (Neuroscience and Hematology), Maternal fetal and Rheumatology to ensure optimal positioning, indication sequencing and value creation within the Regional Portfolio
• As a member of Global teams (e.g. Global Commercial Team (GCT) comprising Strategic Marketing, Market Research, Global Strategic Analytics, and Health Economics & Pricing) is responsible to develop and execute the strategy for brand
• Supports actively GCT and Clinical Development Teams (CDTs) with specific data, documentation
• Ensures that Value Excellence is incorporated into all aspects of the Local and Regional commercial strategy and tactics maintaining and updating the Brand Value Plan, by following the Value Excellence framework in accordance to product life cycle stages
• Is responsible for regional launch readiness plans of new indications and facilitating best practice sharing during the post launch phase; develops metrics for managing brand performance and identifies critical opportunities and risks within the plan
• Participates actively to discussion on Health Economics, providing thoughtful input to ensure optimized market access, pricing, and reimbursement within the evolving healthcare landscapes
• Proactively partners with Medical Affairs and R&D to provide input into clinical study development, product development decisions, and labelling that support the commercial launch strategy in EMEA and lifecycle management investments
• Leads the EMEA Integrated Brand Value Team (comprised of Regulatory, Medical Affairs and HEMAR), providing commercial strategic leadership and guidance into the brand regulatory strategy, medical affairs strategy, publication strategy, market access/reimbursement strategies, and other market preparation programs from full development through the lifecycle of the compound
• Leads a team of European Product Managers (EPMs) and European Brand Leads (EBLs) to develop and execute the commercial strategy and tactics engaging third party vendors as appropriate, ensuring efficiencies in planning and execution at every level by making investment trade-offs across the marketing mix
• Leads Country Value Team Leaders (CVTLs) network ensuring connectivity with EMEA Integrated Brand Value Team and drives strategic alignment across the Region
• Catalyzes innovation and is a change agent to challenging and optimizing Go To Market Models at a local level, linked to Regional Brand Optimization
• Leverages on his / her network of Healthcare Professional (HCP) Key Opinion Leaders (KOLs) and other key stakeholders, providing KOLs and key stakeholders’ insight in order to incorporate in the brand strategy customer needs and realize the economic value proposition
• Is responsible for managing full brand budget across the region
• Leads the development of brand forecasts and indication valuation in collaboration with the Global Commercial Strategy Organization (GCSO) and Regional Analytics team. Progresses critical commercial strategy decisions throughout appropriate governance committees
• Supports the RCSL identifying Regional Life Cycle Opportunities and creating business cases for new EMEA investments
• Selects, develops, and retains talent. Conducting annual performance reviews with direct reports to help support the creation of a diverse, high performing EMEA Commercial Strategy Organization
• Is an inspirational leader applying networking and collaboration competencies across the teams. Ensures Credo Values are demonstrated in the day to day interactions of the IBVT
• Is responsible for sharing best practices and learnings in term of processes, deliverables, approaches